Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:00 PM
Ignite Modification Date:
2025-12-24 @ 2:00 PM
NCT ID:
NCT02032095
Eligibility Criteria:
Inclusion Criteria:
* Patients with stage 4 or 5 on the CKD classification.
* Of the patients that wants a living-donor kidney transplant of ABO blood type compatible, patients with positive FCXM-T and negative CDC-T to the donor.
* Patients with positive FCXM-T after performing twice DFPP therapy
Exclusion Criteria:
* Patients who had taking to continue immunosuppressive drugs or steroids within 4 weeks before obtaining informed consent.
* Patients who had IVIG therapy, or plasmapheresis therapy within 12 weeks before to informed consent.
* Patients who had Rituximab within 6 month before to informed consent.
* Patients who have undergone splenectomy.
* Patients with severe hepatic disorder or severe heart disorder.
* Patients with receiving treatment of malignancy.
* Patients with high risk of thromboembolism.
* Patients with history of shock or hypersensitivity to GB-0998.
* Patients with hereditary fructose intolerance or IgA deficiency.
* Patients with pregnant or probably pregnant.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Study:
NCT02032095
Study Brief:
Protocol Section:
NCT02032095